Ed Sitar

Ed Sitar Email and Phone Number

Chief Financial Officer @ PreciseDx
Mahwah, NJ, US
Ed Sitar's Location
Township of Mahwah, New Jersey, United States, United States
About Ed Sitar

A successful CFO in both public and private companies. Experience includes healthcare IT and services, medical devices and pharmaceuticals ranging from pure start-ups to the revenue in hundreds of millions. Strong revenue and operational focus, capitalizes on the strategic opportunities in an organization. Builds successful teams and holds them accountable and gives them the credit they deserve. Hands on leader, who “checks his ego at the door" and does the right things to get the job done.Winner - NJBIZ CFO of the year - Public Company - 2015 KEY COMPETENCIES AND ACCOMPLISHMENTS#FUNDRAISING - Raised more than $150 million of capital from both private and public equity and debt sources. CUSTOMER ACQUISITION AND RETENTION - Lead executive on new $25 million account. Delivered more than $300 million of savings to the client, a return > 500%. UNIQUE ANALYTICAL FOCUS - Secured and retained more that $50 million of revenue by developing and implementing new pricing models which included significant risk and gain share.INTELLECTUAL PROPERTY - Resolved multiple patent matters in ways that were financially favorable to the Company.REGULATORY - Secured regulatory approval for a device already in the market.SYSTEM DEVELOPMENT - Led IT functions and delivered high service levels and reduced operating costs.ACQUISITIONS AND JOINT VENTURES - Participated in multiple acquisitions and JV arrangements. CPA licensed in New JerseySpecialties: #LifeSciences, #Healthcare, #ThirdPartyReimbursement,#PrivateEquity, #M&A, #VentureFinancing, #BusinessPlanning, #Forecasting, #accountancy, budgeting, business plans, business systems analysis, executive management, finance, financial, forecasting, #fundraising (private equity and public), inventory management, legal, IT, pricing, re-engineering, strategic, #taxplanning, capital raising,

Ed Sitar's Current Company Details
PreciseDx

Precisedx

View
Chief Financial Officer
Mahwah, NJ, US
Website:
precisedx.ai
Employees:
28
Ed Sitar Work Experience Details
  • Precisedx
    Chief Financial Officer
    Precisedx
    Mahwah, Nj, Us
  • Timber Pharmaceuticals
    Lead Independent Director And Audit Committee Chair
    Timber Pharmaceuticals May 2020 - May 2024
    Madison, New Jersey, Us
    Timber Pharmaceuticals is building an orphan dermatology organization that focuses on mitigating the cost, risk, and time of drug development by leveraging the Orphan Drug pathway for conditions with no FDA Approved treatments. The company’s investigational therapies have proven mechanisms-of-action backed by decades of clinical experience and well-established CMC (chemistry, manufacturing and control) and safety profiles. Timber is initially focused on developing non-systemic treatments for rare dermatologic diseases including congenital ichthyosis (CI), tuberous sclerosis complex (TSC), and localized scleroderma.
  • Variantyx
    Chief Financial Officer
    Variantyx Jan 2022 - Jan 2024
    Framingham, Massachusetts, Us
    Variantyx is a technology-driven precision medicine company providing disruptive solutions to the genetic disorders, reproductive health, and precision oncology markets. Variantyx's whole genome analysis platform allows a better understanding of a person's genetic makeup, leading to unmatched diagnostic capabilities and improved personalized treatment recommendations.
  • 9 Meters Biopharma, Inc.
    Chief Financial Officer
    9 Meters Biopharma, Inc. Jul 2019 - Jan 2022
    9 Meters Biopharma is the new company formed from the merger of Innovate Biopharmaceuticals and RDD Pharma and NAIA Rare Diseases. I was the leader in that strategic transaction. Since the merger I was instrumental in:• Raising over $100 million of new capital;• Increasing institutional ownership in the shareholder base from 9% to more than 50%;• Increasing the market capitalization to allow us to join the Russell 2000;• Lead investor relations outreach with my deep relationships on the buy side and Wall Street;• Obtained coverage from eight (8) analysts and improving our financial profile so we are now served by "household name" Investment Banks.• Transitioned merger and corporate structure issues (e.g. mergers, dealing with securities from predecessor companies, managing new shareholder votes on amendments to our corporate structure); and • Developed and improving high level systems which resulted in the material weakness audit report being removed.
  • Caredox, Inc.
    Acting Chief Financial Officer
    Caredox, Inc. Feb 2019 - Jun 2019
    Ramsey, Nj, Us
    Worked with Series C healthcare technology company in business model rationalization and acquisition integration
  • Ammon Analytical Laboratory
    Chief Financial Officer
    Ammon Analytical Laboratory Apr 2017 - Nov 2018
    Linden, New Jersey, Us
    Ammon Labs is a leader in specialty testing for the drug treatment community. As a result of my efforts the value of the Company tripled. Significant accomplishments included:• Revenue increased 70% while specimen counts were flat;• Securing national and regional payer contracts• Implementing financial procedures (where none existed) and upgraded HR including implementing a budget/F,P&A function and establishing internal recruiting function• Accessing more than $6 million of financing to support the Company’s growth• Improved risk management function to obtain coverage for areas previously neglected
  • Cancer Genetics, Inc.
    Chief Financial Officer
    Cancer Genetics, Inc. Mar 2014 - Feb 2017
    Cherry Hill, Nj, Us
    Cancer Genetics, Inc. is an emerging personalized medicine company with unique diagnostic technology that can help providers deliver precise treatments to patients with difficult to treat blood borne and urogenital cancers. I was the public facing CFO responsible for all finances including SEC reporting, IR, third party reimbursement and HR.• Led three acquisitions that quadrupled the size of the Company• Reorganized the third party billing and reimbursement functions to significantly improve long term reimbursement results• Refinanced the Company’s debt releasing onerous collateral requirements
  • Healthagen, An Aetna Company
    Cfo - New Business
    Healthagen, An Aetna Company Jan 2013 - Dec 2013
    Healthagen acquires, builds and supports new businesses that have unique technologies or capabilities that will transform healthcare. I am the financial executive responsible for leading the businesses out of the concept state to commercialization. My broad skills in finance, legal, intellectual property, operations and regulatory contribute to the success of these organizations.
  • Activehealth Management
    Cfo
    Activehealth Management 2010 - 2012
    New York, Ny, Us
    ActiveHealth, a subsidiary of Aetna ,is the market leader in clinical decision support systems. AHM's technology supports the transformation of current payer systems to ACO and PCMH models. As CFO I support the transformation of our customer businesses with responsibility for deal pricing in addition to accounting and other finance functions. During my tenure cost footprint was reduced by $30 million.
  • Cadent Holdings, Inc
    Executive Vice President And Chief Financial Officer
    Cadent Holdings, Inc 2001 - 2011
    Lead US executive for venture backed high technology company. Recapitalized Company from Israel to Delaware. Developed and implemented tax plan to minimize US and international burden. Led fundraising for more than $120 million of financing that introduced new lead investors and lending sources. Lead legal and regulatory function and intimately involved in sales and marketing, operations and business plan development.
  • Bioscrip (Formerly Mim Corp)
    Cfo
    Bioscrip (Formerly Mim Corp) 1998 - 2001
    Executive responsible for the financial affairs of a $600 million decentralized pharmacy benefit management, specialty pharmacy and e-commerce/fulfillment company. Key participant in all major decisions. Developed strategy for future development of business. Evaluated and negotiated with acquisition and merger candidates. Successfully negotiated Company’s first financing facility.
  • Vital Signs, Inc
    Vice President - Finance
    Vital Signs, Inc 1996 - 1998
    Executive responsible for the financial affairs and business systems of a $140 million dollar publicly traded manufacturer and distributor of disposable medical products. Led re-engineering studies and implementation of changes of both the executive management and MIS areas of the company. Key team member in evaluation of acquisition and joint venture opportunities. Oversee the operations of non-local subsidiaries. Lead role in developing the Company's response to contracting with managed care and group purchasing organizations
  • Zenith/Goldline Pharmaceuticals, Inc
    Controller
    Zenith/Goldline Pharmaceuticals, Inc 1993 - 1996
    Directed the financial affairs of a $500 million multisource pharmaceutical manufacturer and distributor. Responsible for accounting, tax, management information systems, inventory control, budgeting and forecasting. Managed a staff of thirty-five professionals. Interfaced directly with chief executive officer and chairman of the board of directors. Extensive involvement in operations at all the company's facilities (including seven manufacturing plants and four distribution locations). Directly involved in the acquisition of Zenith Laboratories
  • Pwc (Coopers & Lybrand)
    Senior Manager, Emerging Business Service Team
    Pwc (Coopers & Lybrand) 1982 - 1993
    Led audits of various size organizations in the Healthcare, Consumer Product and Education industries

Ed Sitar Education Details

  • University Of Scranton
    University Of Scranton
    Accounting
  • Saint Joseph High School- Metuchen, Nj
    Saint Joseph High School- Metuchen, Nj
    College Preparation
  • St Mary'S Plainfield
    St Mary'S Plainfield
    General Studies

Frequently Asked Questions about Ed Sitar

What company does Ed Sitar work for?

Ed Sitar works for Precisedx

What is Ed Sitar's role at the current company?

Ed Sitar's current role is Chief Financial Officer.

What is Ed Sitar's email address?

Ed Sitar's email address is ed****@****gix.com

What is Ed Sitar's direct phone number?

Ed Sitar's direct phone number is +120152*****

What schools did Ed Sitar attend?

Ed Sitar attended University Of Scranton, Saint Joseph High School- Metuchen, Nj, St Mary's Plainfield.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.